No 100% this quarter AL was very clear on this.
Concentrating on recoveries and costs, should be a record production and sales Quarter but not a huge gamechanger if not for the interest costs being slashed.
Importantly the extra free cashflow from the deal is needed for the mining campaing which is what is actualy holding up final ramp up.
"100% and beyond" is 3-6 months away, importantly this has been made possible by the debt deal regardless of RE prices which make any rises a bonus
Cost of production at beyond nameplate has clearly been beyond most peoples comprehensions at this stage and still seems to be for some strange reason.
With a plant like this SIZE IS VERY IMPORTANT, you can't make a plant smaller AND reduce cost of production as some other players are suggesting (NTU perhaps).
Reading about the history of manufacturing would be very handy to understand the cost benefits of running a HUGE operation and it's effect on cost per unit.
- Forums
- ASX - By Stock
- LYC
- Asian Metal RE prices up again
Asian Metal RE prices up again, page-23
-
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
|
|||||
Last
$6.40 |
Change
0.000(0.00%) |
Mkt cap ! $5.982B |
Open | High | Low | Value | Volume |
$6.47 | $6.48 | $6.34 | $20.28M | 3.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12848 | $6.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.40 | 17965 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3600 | 6.360 |
1 | 15000 | 6.350 |
2 | 260 | 6.340 |
3 | 4563 | 6.330 |
4 | 8665 | 6.310 |
Price($) | Vol. | No. |
---|---|---|
6.400 | 10000 | 1 |
6.410 | 24000 | 1 |
6.420 | 203 | 1 |
6.450 | 3291 | 2 |
6.480 | 2100 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
LYC (ASX) Chart |